Seroprotection rates after late doses of hepatitis B vaccine.
Duval
Bernard
B
Deceuninck
Genevieve
G
D000293:Adolescent; D000917:Antibody Formation / Q000276:immunology; D004306:Dose-Response Relationship, Immunologic; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000097:blood / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006568:Herpesvirus 1, Cercopithecine / Q000276:immunology; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D012107:Research Design / Q000592:standards; D013997:Time Factors
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines